Drug information for ZIDOVUDINE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
100MG
Tentative Approval
ZIDOVUDINE
Zidovudine
BARR
74047
CAPSULE; ORAL
100MG
Prescription
AB
ZIDOVUDINE
Zidovudine
AUROBINDO PHARMA LTD
78128
2006-04-05 Letter
CAPSULE; ORAL
100MG
Prescription
AB
ZIDOVUDINE
Zidovudine
CIPLA LTD
78349
2007-05-29 Letter
INJECTABLE; INJECTION
10MG/ML
Prescription
AP
ZIDOVUDINE
Zidovudine
LUITPOLD
91457
SYRUP; ORAL
50MG/5ML
Prescription
AA
ZIDOVUDINE
Zidovudine
AUROBINDO
77268
2005-09-22 Letter
2005-09-14 Letter
SYRUP; ORAL
50MG/5ML
Prescription
AA
ZIDOVUDINE
Zidovudine
CIPLA LTD
77981
2008-07-01 Letter
TABLET; ORAL
100MG
Discontinued
ZIDOVUDINE
Zidovudine
MATRIX LABS LTD
200732
2011-06-29 Review
2011-03-04 Label
2011-02-28 Letter
TABLET; ORAL
300MG
Prescription
AB
ZIDOVUDINE
Zidovudine
HEC PHARM INC
202058
2011-10-12 Letter
TABLET; ORAL
60MG
Discontinued
ZIDOVUDINE
Zidovudine
AUROBINDO PHARMA
22294
2011-01-05 Letter
2011-01-04 Label
2009-11-10 Review
2009-11-10 Summary Review
2009-07-31 Letter
2009-07-30 Label
TABLET; ORAL
300MG
Prescription
AB
ZIDOVUDINE
Zidovudine
ROXANE
76844
2005-09-22 Letter
TABLET; ORAL
300MG
Prescription
AB
ZIDOVUDINE
Zidovudine
AUROBINDO
77267
2005-09-22 Letter
TABLET; ORAL
300MG
Prescription
AB
ZIDOVUDINE
Zidovudine
RANBAXY
77327
2005-09-22 Letter
TABLET; ORAL
300MG
Prescription
AB
ZIDOVUDINE
Zidovudine
MATRIX LABS LTD
78922
2008-02-19 Letter
TABLET; ORAL
300MG
Prescription
AB
ZIDOVUDINE
Zidovudine
HETERO DRUGS LTD
90092
2008-04-28 Letter
TABLET; ORAL
300MG
Prescription
AB
ZIDOVUDINE
Zidovudine
CIPLA
90561
2010-11-03 Letter
Drug Adverse Effects information for ZIDOVUDINE
Role code
Indications
Reaction
# Reports
PS
ACQUIRED IMMUNODEFICIENCY SYNDROME
FOETAL GROWTH RESTRICTION
1
PS
ACQUIRED IMMUNODEFICIENCY SYNDROME
MATERNAL DRUGS AFFECTING FOETUS
1
PS
ACQUIRED IMMUNODEFICIENCY SYNDROME
PREMATURE BABY
1
PS
ANTIRETROVIRAL THERAPY
ALANINE AMINOTRANSFERASE INCREASED
1
PS
ANTIRETROVIRAL THERAPY
ANAEMIA
2
PS
ANTIRETROVIRAL THERAPY
ASPARTATE AMINOTRANSFERASE INCREASED
1
PS
ANTIRETROVIRAL THERAPY
ATRIAL SEPTAL DEFECT
1
PS
ANTIRETROVIRAL THERAPY
BILIRUBIN CONJUGATED INCREASED
1
PS
ANTIRETROVIRAL THERAPY
BLOOD ALBUMIN DECREASED
1
PS
ANTIRETROVIRAL THERAPY
BLOOD ALKALINE PHOSPHATASE INCREASED
1
PS
ANTIRETROVIRAL THERAPY
BLOOD BILIRUBIN INCREASED
1
PS
ANTIRETROVIRAL THERAPY
BOVINE TUBERCULOSIS
4
PS
ANTIRETROVIRAL THERAPY
CAESAREAN SECTION
1
PS
ANTIRETROVIRAL THERAPY
CONGENITAL ANOMALY IN OFFSPRING
5
PS
ANTIRETROVIRAL THERAPY
COUGH
3
PS
ANTIRETROVIRAL THERAPY
DEHYDRATION
1
PS
ANTIRETROVIRAL THERAPY
DEVELOPMENTAL DELAY
4
PS
ANTIRETROVIRAL THERAPY
DIARRHOEA
1
PS
ANTIRETROVIRAL THERAPY
DIARRHOEA NEONATAL
1
PS
ANTIRETROVIRAL THERAPY
DYSLIPIDAEMIA
9
PS
ANTIRETROVIRAL THERAPY
DYSPNOEA
3
PS
ANTIRETROVIRAL THERAPY
ENOPHTHALMOS
2
PS
ANTIRETROVIRAL THERAPY
FAECES DISCOLOURED
1
PS
ANTIRETROVIRAL THERAPY
FOETAL EXPOSURE DURING PREGNANCY
7
PS
ANTIRETROVIRAL THERAPY
GAMMA-GLUTAMYLTRANSFERASE INCREASED
1
PS
ANTIRETROVIRAL THERAPY
GLUCOSE TOLERANCE IMPAIRED
6
PS
ANTIRETROVIRAL THERAPY
HEPATIC FUNCTION ABNORMAL
1
PS
ANTIRETROVIRAL THERAPY
HEPATOMEGALY
4
PS
ANTIRETROVIRAL THERAPY
HEPATOSPLENOMEGALY
3
PS
ANTIRETROVIRAL THERAPY
HEPATOTOXICITY
4
PS
ANTIRETROVIRAL THERAPY
HIGH DENSITY LIPOPROTEIN DECREASED
6
PS
ANTIRETROVIRAL THERAPY
HYPERTRIGLYCERIDAEMIA
6
PS
ANTIRETROVIRAL THERAPY
IMMUNE RECONSTITUTION SYNDROME
4
PS
ANTIRETROVIRAL THERAPY
INTRA-UTERINE DEATH
22
PS
ANTIRETROVIRAL THERAPY
JAUNDICE
1
PS
ANTIRETROVIRAL THERAPY
LACTIC ACIDOSIS
7
PS
ANTIRETROVIRAL THERAPY
LAGOPHTHALMOS
2
PS
ANTIRETROVIRAL THERAPY
LIPOATROPHY
8
PS
ANTIRETROVIRAL THERAPY
LOW BIRTH WEIGHT BABY
1
PS
ANTIRETROVIRAL THERAPY
LYMPHADENITIS
3
PS
ANTIRETROVIRAL THERAPY
LYMPHADENOPATHY
3
PS
ANTIRETROVIRAL THERAPY
MATERNAL DRUGS AFFECTING FOETUS
1
PS
ANTIRETROVIRAL THERAPY
MATERNAL EXPOSURE DURING PREGNANCY
29
PS
ANTIRETROVIRAL THERAPY
MUSCLE SPASTICITY
3
PS
ANTIRETROVIRAL THERAPY
NEONATAL ASPIRATION
1
PS
ANTIRETROVIRAL THERAPY
PREGNANCY
12
PS
ANTIRETROVIRAL THERAPY
PYREXIA
3
PS
ANTIRETROVIRAL THERAPY
RENAL FAILURE ACUTE
3
PS
ANTIRETROVIRAL THERAPY
THROMBOCYTOPENIA
1
PS
ANTIRETROVIRAL THERAPY
TYPE 2 DIABETES MELLITUS
9
PS
ANTIRETROVIRAL THERAPY
VENTRICULAR SEPTAL DEFECT
1
PS
ANTIVIRAL PROPHYLAXIS
ACIDOSIS
1
PS
ANTIVIRAL PROPHYLAXIS
ALANINE AMINOTRANSFERASE INCREASED
1
PS
ANTIVIRAL PROPHYLAXIS
BLOOD LACTIC ACID INCREASED
1
PS
ANTIVIRAL PROPHYLAXIS
FOETAL EXPOSURE DURING PREGNANCY
1
PS
ANTIVIRAL PROPHYLAXIS
INCORRECT DOSE ADMINISTERED
1
PS
ANTIVIRAL PROPHYLAXIS
NEUTROPENIA NEONATAL
1
PS
ANTIVIRAL PROPHYLAXIS
SINUS BRADYCARDIA
1
PS
ANTIVIRAL TREATMENT
ASCITES
11
PS
ANTIVIRAL TREATMENT
CHOLESTASIS
11
PS
ANTIVIRAL TREATMENT
CONGENITAL ANOMALY
6
PS
ANTIVIRAL TREATMENT
FOETAL EXPOSURE DURING PREGNANCY
6
PS
ANTIVIRAL TREATMENT
FOETAL GROWTH RESTRICTION
7
PS
ANTIVIRAL TREATMENT
HAEMATOTOXICITY
11
PS
ANTIVIRAL TREATMENT
HYPOPHOSPHATAEMIA
11
PS
ANTIVIRAL TREATMENT
IRON DEFICIENCY ANAEMIA
11
PS
ANTIVIRAL TREATMENT
LIPOATROPHY
11
PS
ANTIVIRAL TREATMENT
LIVER DISORDER
11
PS
ANTIVIRAL TREATMENT
MATERNAL DRUGS AFFECTING FOETUS
1
PS
ANTIVIRAL TREATMENT
OESOPHAGEAL VARICES HAEMORRHAGE
11
PS
ANTIVIRAL TREATMENT
PORTAL HYPERTENSION
11
PS
ANTIVIRAL TREATMENT
PORTAL VEIN THROMBOSIS
11
PS
ANTIVIRAL TREATMENT
PREMATURE BABY
7
PS
ANTIVIRAL TREATMENT
PROTEINURIA
11
PS
ANTIVIRAL TREATMENT
SPLENOMEGALY
11
PS
ANTIVIRAL TREATMENT
TRANSAMINASES INCREASED
11
PS
ANTIVIRAL TREATMENT
VIROLOGIC FAILURE
11
PS
CONTRACEPTION
DRUG INEFFECTIVE
2
PS
CONTRACEPTION
DRUG INTERACTION
2
PS
CONTRACEPTION
ECTOPIC PREGNANCY
2
PS
EXPOSURE TO COMMUNICABLE DISEASE
NYSTAGMUS
2
PS
HIV INFECTION
ABDOMINAL DISTENSION
7
PS
HIV INFECTION
ABDOMINAL HERNIA
7
PS
HIV INFECTION
ABDOMINAL PAIN
3
PS
HIV INFECTION
ABDOMINAL PAIN UPPER
3
PS
HIV INFECTION
ACCIDENTAL OVERDOSE
1
PS
HIV INFECTION
ACIDOSIS
3
PS
HIV INFECTION
ALANINE AMINOTRANSFERASE INCREASED
4
PS
HIV INFECTION
ANAEMIA
1
PS
HIV INFECTION
ANAEMIA MACROCYTIC
1
PS
HIV INFECTION
ARTHRALGIA
6
PS
HIV INFECTION
ARTHRITIS
6
PS
HIV INFECTION
ATRIAL SEPTAL DEFECT
10
PS
HIV INFECTION
BLOOD LACTIC ACID INCREASED
3
PS
HIV INFECTION
BLOOD THYROID STIMULATING HORMONE INCREASED
6
PS
HIV INFECTION
BLOOD TRIGLYCERIDES INCREASED
8
PS
HIV INFECTION
CAESAREAN SECTION
4
PS
HIV INFECTION
CARDIAC MURMUR
7
PS
HIV INFECTION
CELL DEATH
3
PS
HIV INFECTION
CEREBRAL VENTRICLE DILATATION
4
PS
HIV INFECTION
CHOLANGITIS
3
PS
HIV INFECTION
CHOLESTASIS
3
PS
HIV INFECTION
CLEFT PALATE
4
PS
HIV INFECTION
CONDITION AGGRAVATED
7
PS
HIV INFECTION
CONGENITAL ANOMALY
15
PS
HIV INFECTION
CONGENITAL CYTOMEGALOVIRUS INFECTION
6
PS
HIV INFECTION
CONGENITAL FOOT MALFORMATION
6
PS
HIV INFECTION
CONGENITAL INGUINAL HERNIA
3
PS
HIV INFECTION
CONGENITAL NAEVUS
3
PS
HIV INFECTION
CONGENITAL NAIL DISORDER
2
PS
HIV INFECTION
CONGENITAL NYSTAGMUS
5
PS
HIV INFECTION
CRYOGLOBULINS PRESENT
6
PS
HIV INFECTION
CRYPTORCHISM
7
PS
HIV INFECTION
CRYPTOSPORIDIOSIS INFECTION
3
PS
HIV INFECTION
DANDY-WALKER SYNDROME
4
PS
HIV INFECTION
DIARRHOEA
3
PS
HIV INFECTION
DRUG INEFFECTIVE
10
PS
HIV INFECTION
DRUG INTERACTION
10
PS
HIV INFECTION
DRY EYE
2
PS
HIV INFECTION
DYSPHAGIA
4
PS
HIV INFECTION
DYSPHONIA
6
PS
HIV INFECTION
ECONOMIC PROBLEM
8
PS
HIV INFECTION
ECTOPIC PREGNANCY
10
PS
HIV INFECTION
ENOPHTHALMOS
4
PS
HIV INFECTION
EXOMPHALOS
7
PS
HIV INFECTION
EYELID DISORDER
2
PS
HIV INFECTION
EYES SUNKEN
2
PS
HIV INFECTION
FACIAL WASTING
2
PS
HIV INFECTION
FOETAL EXPOSURE DURING PREGNANCY
3
PS
HIV INFECTION
FOETAL GROWTH RESTRICTION
7
PS
HIV INFECTION
GASTROINTESTINAL DISORDER
10
PS
HIV INFECTION
GASTROINTESTINAL HAEMORRHAGE
1
PS
HIV INFECTION
GASTROSCHISIS
7
PS
HIV INFECTION
GENERALISED OEDEMA
6
PS
HIV INFECTION
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
8
PS
HIV INFECTION
HAEMANGIOMA CONGENITAL
6
PS
HIV INFECTION
HAEMOGLOBIN DECREASED
8
PS
HIV INFECTION
HEPATIC CYST
14
PS
HIV INFECTION
HYDROCELE
8
PS
HIV INFECTION
HYDROCEPHALUS
3
PS
HIV INFECTION
HYPERSENSITIVITY
3
PS
HIV INFECTION
HYPERTHYROIDISM
6
PS
HIV INFECTION
HYPOTHYROIDISM
6
PS
HIV INFECTION
HYPOTONIA NEONATAL
4
PS
HIV INFECTION
IMMUNE RECONSTITUTION SYNDROME
22
PS
HIV INFECTION
INCORRECT DOSE ADMINISTERED
3
PS
HIV INFECTION
INTRA-ABDOMINAL HAEMANGIOMA
3
PS
HIV INFECTION
JAUNDICE
5
PS
HIV INFECTION
LAGOPHTHALMOS
4
PS
HIV INFECTION
LETHARGY
6
PS
HIV INFECTION
LIPOATROPHY
6
PS
HIV INFECTION
LIPODYSTROPHY ACQUIRED
10
PS
HIV INFECTION
MATERNAL DRUGS AFFECTING FOETUS
97
PS
HIV INFECTION
MATERNAL EXPOSURE DURING PREGNANCY
3
PS
HIV INFECTION
MEDICATION ERROR
1
PS
HIV INFECTION
METABOLIC ACIDOSIS
1
PS
HIV INFECTION
MITOCHONDRIAL TOXICITY
8
PS
HIV INFECTION
MOBILITY DECREASED
8
PS
HIV INFECTION
MYASTHENIA GRAVIS
10
PS
HIV INFECTION
NEOPLASM MALIGNANT
6
PS
HIV INFECTION
NEUROPATHY PERIPHERAL
4
PS
HIV INFECTION
NEUTROPENIA
1
PS
HIV INFECTION
NEUTROPENIA NEONATAL
3
PS
HIV INFECTION
ORBIT ATROPHY
2
PS
HIV INFECTION
OSTEONECROSIS
28
PS
HIV INFECTION
OSTEOPOROSIS
7
PS
HIV INFECTION
PIERRE ROBIN SYNDROME
4
PS
HIV INFECTION
PILONIDAL CYST CONGENITAL
5
PS
HIV INFECTION
PLAGIOCEPHALY
3
PS
HIV INFECTION
POOR SUCKING REFLEX
4
PS
HIV INFECTION
PORTAL HYPERTENSION
52
PS
HIV INFECTION
POSTMATURE BABY
4
PS
HIV INFECTION
PREMATURE BABY
6
PS
HIV INFECTION
PRODUCT CONTAMINATION
4
PS
HIV INFECTION
PULMONARY ARTERIAL HYPERTENSION
8
PS
HIV INFECTION
PULMONARY ARTERY STENOSIS
2
PS
HIV INFECTION
PULMONARY ARTERY STENOSIS CONGENITAL
3
PS
HIV INFECTION
PULMONARY TUBERCULOSIS
10
PS
HIV INFECTION
PULMONARY VALVE STENOSIS
2
PS
HIV INFECTION
PULMONARY VALVE STENOSIS CONGENITAL
3
PS
HIV INFECTION
PUNCTATE KERATITIS
2
PS
HIV INFECTION
RASH
5
PS
HIV INFECTION
RETROGNATHIA
4
PS
HIV INFECTION
RHEUMATOID ARTHRITIS
6
PS
HIV INFECTION
RHEUMATOID FACTOR INCREASED
6
PS
HIV INFECTION
SICKLE CELL ANAEMIA
23
PS
HIV INFECTION
SINUS BRADYCARDIA
3
PS
HIV INFECTION
SPLENOMEGALY
14
PS
HIV INFECTION
SQUAMOUS CELL CARCINOMA OF SKIN
6
PS
HIV INFECTION
SYNOVITIS
6
PS
HIV INFECTION
TALIPES
3
PS
HIV INFECTION
TERATOMA
3
PS
HIV INFECTION
THALASSAEMIA
3
PS
HIV INFECTION
TOXICITY TO VARIOUS AGENTS
1
PS
HIV INFECTION
TREATMENT FAILURE
10
PS
HIV INFECTION
TRISOMY 21
8
PS
HIV INFECTION
TUBERCULOSIS
3
PS
HIV INFECTION
UMBILICAL HERNIA
7
PS
HIV INFECTION
WATER POLLUTION
3
PS
HIV INFECTION
WEIGHT DECREASED
3
PS
HIV INFECTION
WEIGHT INCREASED
6
PS
HIV INFECTION
WOUND
6
PS
MYASTHENIA GRAVIS
CONDITION AGGRAVATED
1
PS
MYASTHENIA GRAVIS
IMMUNE RECONSTITUTION SYNDROME
2
PS
MYASTHENIA GRAVIS
JAUNDICE
1
PS
MYASTHENIA GRAVIS
MYASTHENIA GRAVIS
2
PS
MYASTHENIA GRAVIS
RASH
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
ABDOMINAL DISTENSION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
ABDOMINAL HERNIA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
BOVINE TUBERCULOSIS
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CAESAREAN SECTION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CARDIAC MURMUR
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CEREBRAL VENTRICLE DILATATION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CLEFT PALATE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CONGENITAL ANOMALY
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CONGENITAL NAIL DISORDER
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
COUGH
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
CRYPTORCHISM
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
DANDY-WALKER SYNDROME
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
DYSPHAGIA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
DYSPNOEA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
EXOMPHALOS
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
FOETAL EXPOSURE DURING PREGNANCY
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
FOETAL GROWTH RESTRICTION
6
PS
PRODUCT USED FOR UNKNOWN INDICATION
GASTROSCHISIS
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATOMEGALY
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATOTOXICITY
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
HYPERSENSITIVITY
3
PS
PRODUCT USED FOR UNKNOWN INDICATION
HYPOTONIA NEONATAL
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
IMMUNE RECONSTITUTION SYNDROME
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
LACTIC ACIDOSIS
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
MATERNAL DRUGS AFFECTING FOETUS
3
PS
PRODUCT USED FOR UNKNOWN INDICATION
MATERNAL EXPOSURE DURING PREGNANCY
8
PS
PRODUCT USED FOR UNKNOWN INDICATION
MITOCHONDRIAL TOXICITY
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
PIERRE ROBIN SYNDROME
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
POOR SUCKING REFLEX
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
POSTMATURE BABY
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
PREMATURE BABY
5
PS
PRODUCT USED FOR UNKNOWN INDICATION
PRODUCT CONTAMINATION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
PYREXIA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
RENAL FAILURE ACUTE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
RETROGNATHIA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
UMBILICAL HERNIA
1
PS
PROPHYLAXIS
DEVELOPMENTAL DELAY
1
PS
PROPHYLAXIS
FOETAL EXPOSURE DURING PREGNANCY
1
PS
PROPHYLAXIS
HEPATOSPLENOMEGALY
1
PS
PROPHYLAXIS
LACTIC ACIDOSIS
1
PS
PROPHYLAXIS
LYMPHADENITIS
1
PS
PROPHYLAXIS
LYMPHADENOPATHY
1
PS
PROPHYLAXIS
MUSCLE SPASTICITY
1
PS
PROPHYLAXIS AGAINST HIV INFECTION
ACCIDENTAL OVERDOSE
1
PS
PROPHYLAXIS AGAINST HIV INFECTION
ASPARTATE AMINOTRANSFERASE INCREASED
2
PS
PROPHYLAXIS AGAINST HIV INFECTION
BLOOD LACTIC ACID INCREASED
1
PS
PROPHYLAXIS AGAINST HIV INFECTION
MEDICATION ERROR
1
PS
PROPHYLAXIS AGAINST HIV INFECTION
METABOLIC ACIDOSIS
2
PS
PROPHYLAXIS AGAINST HIV INFECTION
NEUTROPENIA
2
PS
PROPHYLAXIS AGAINST HIV INFECTION
NYSTAGMUS
2
PS
PROPHYLAXIS AGAINST HIV INFECTION
OVERDOSE
1
PS
PROPHYLAXIS AGAINST HIV INFECTION
TOXICITY TO VARIOUS AGENTS
1
PS
TUBERCULOSIS
BOVINE TUBERCULOSIS
7
PS
TUBERCULOSIS
HEPATOTOXICITY
7
PS
TUBERCULOSIS
IMMUNE RECONSTITUTION SYNDROME
7
PS
URTICARIA
ACIDOSIS
1
PS
URTICARIA
ALANINE AMINOTRANSFERASE INCREASED
1
PS
URTICARIA
BLOOD LACTIC ACID INCREASED
1
PS
URTICARIA
FOETAL EXPOSURE DURING PREGNANCY
1
PS
URTICARIA
INCORRECT DOSE ADMINISTERED
1
PS
URTICARIA
NEUTROPENIA NEONATAL
1
PS
URTICARIA
SINUS BRADYCARDIA
1
SS
ANTIRETROVIRAL THERAPY
ALANINE AMINOTRANSFERASE INCREASED
1
SS
ANTIRETROVIRAL THERAPY
ANAEMIA
3
SS
ANTIRETROVIRAL THERAPY
ARRHYTHMIA
3
SS
ANTIRETROVIRAL THERAPY
ASCITES
3
SS
ANTIRETROVIRAL THERAPY
ASPARTATE AMINOTRANSFERASE INCREASED
4
SS
ANTIRETROVIRAL THERAPY
ATRIAL SEPTAL DEFECT
1
SS
ANTIRETROVIRAL THERAPY
BILIRUBIN CONJUGATED INCREASED
1
SS
ANTIRETROVIRAL THERAPY
BLOOD ALBUMIN DECREASED
1
SS
ANTIRETROVIRAL THERAPY
BLOOD ALKALINE PHOSPHATASE INCREASED
1
SS
ANTIRETROVIRAL THERAPY
BLOOD BILIRUBIN INCREASED
1
SS
ANTIRETROVIRAL THERAPY
CACHEXIA
8
SS
ANTIRETROVIRAL THERAPY
CAESAREAN SECTION
1
SS
ANTIRETROVIRAL THERAPY
CARDIAC FAILURE CONGESTIVE
3
SS
ANTIRETROVIRAL THERAPY
CHRONIC FATIGUE SYNDROME
8
SS
ANTIRETROVIRAL THERAPY
COUGH
3
SS
ANTIRETROVIRAL THERAPY
DEHYDRATION
1
SS
ANTIRETROVIRAL THERAPY
DEPRESSION
8
SS
ANTIRETROVIRAL THERAPY
DEVELOPMENTAL DELAY
10
SS
ANTIRETROVIRAL THERAPY
DIARRHOEA
4
SS
ANTIRETROVIRAL THERAPY
DIARRHOEA NEONATAL
1
SS
ANTIRETROVIRAL THERAPY
DRUG RESISTANCE
15
SS
ANTIRETROVIRAL THERAPY
DYSPNOEA
3
SS
ANTIRETROVIRAL THERAPY
FACIAL WASTING
8
SS
ANTIRETROVIRAL THERAPY
FAECES DISCOLOURED
1
SS
ANTIRETROVIRAL THERAPY
FOETAL EXPOSURE DURING PREGNANCY
13
SS
ANTIRETROVIRAL THERAPY
GAMMA-GLUTAMYLTRANSFERASE INCREASED
1
SS
ANTIRETROVIRAL THERAPY
HEPATIC FUNCTION ABNORMAL
1
SS
ANTIRETROVIRAL THERAPY
HEPATOMEGALY
4
SS
ANTIRETROVIRAL THERAPY
HEPATOSPLENOMEGALY
9
SS
ANTIRETROVIRAL THERAPY
HYPERTENSION
3
SS
ANTIRETROVIRAL THERAPY
HYPOAESTHESIA
8
SS
ANTIRETROVIRAL THERAPY
HYPOTENSION
3
SS
ANTIRETROVIRAL THERAPY
JAUNDICE
1
SS
ANTIRETROVIRAL THERAPY
LACTIC ACIDOSIS
13
SS
ANTIRETROVIRAL THERAPY
LIPODYSTROPHY ACQUIRED
8
SS
ANTIRETROVIRAL THERAPY
LOBAR PNEUMONIA
3
SS
ANTIRETROVIRAL THERAPY
LOW BIRTH WEIGHT BABY
1
SS
ANTIRETROVIRAL THERAPY
LYMPHADENITIS
9
SS
ANTIRETROVIRAL THERAPY
LYMPHADENOPATHY
9
SS
ANTIRETROVIRAL THERAPY
MATERNAL DRUGS AFFECTING FOETUS
1
SS
ANTIRETROVIRAL THERAPY
MENTAL DISORDER
3
SS
ANTIRETROVIRAL THERAPY
MOTOR NEURONE DISEASE
3
SS
ANTIRETROVIRAL THERAPY
MUSCLE SPASTICITY
9
SS
ANTIRETROVIRAL THERAPY
NEONATAL ASPIRATION
1
SS
ANTIRETROVIRAL THERAPY
NEUTROPENIA
3
SS
ANTIRETROVIRAL THERAPY
PEPTIC ULCER
3
SS
ANTIRETROVIRAL THERAPY
PSYCHIATRIC SYMPTOM
15
SS
ANTIRETROVIRAL THERAPY
PYREXIA
3
SS
ANTIRETROVIRAL THERAPY
RASH
3
SS
ANTIRETROVIRAL THERAPY
RENAL FAILURE ACUTE
3
SS
ANTIRETROVIRAL THERAPY
THROMBOCYTOPENIA
3
SS
ANTIRETROVIRAL THERAPY
VASODILATATION
8
SS
ANTIRETROVIRAL THERAPY
VENTRICULAR SEPTAL DEFECT
1
SS
ANTIVIRAL PROPHYLAXIS
ACIDOSIS
1
SS
ANTIVIRAL PROPHYLAXIS
ALANINE AMINOTRANSFERASE INCREASED
1
SS
ANTIVIRAL PROPHYLAXIS
BLOOD LACTIC ACID INCREASED
1
SS
ANTIVIRAL PROPHYLAXIS
FOETAL EXPOSURE DURING PREGNANCY
1
SS
ANTIVIRAL PROPHYLAXIS
INCORRECT DOSE ADMINISTERED
1
SS
ANTIVIRAL PROPHYLAXIS
NEUTROPENIA NEONATAL
1
SS
ANTIVIRAL PROPHYLAXIS
SINUS BRADYCARDIA
1
SS
ANTIVIRAL TREATMENT
ASCITES
2
SS
ANTIVIRAL TREATMENT
CHOLESTASIS
2
SS
ANTIVIRAL TREATMENT
HAEMATOTOXICITY
2
SS
ANTIVIRAL TREATMENT
HEPATIC ENZYME ABNORMAL
2
SS
ANTIVIRAL TREATMENT
PORTAL HYPERTENSION
2
SS
ANTIVIRAL TREATMENT
VIROLOGIC FAILURE
2
SS
ENCEPHALITIS
AMNESIA
2
SS
HIV INFECTION
ACCIDENTAL OVERDOSE
1
SS
HIV INFECTION
ACIDOSIS
3
SS
HIV INFECTION
ACUTE HEPATIC FAILURE
24
SS
HIV INFECTION
ALANINE AMINOTRANSFERASE INCREASED
28
SS
HIV INFECTION
AMNESIA
4
SS
HIV INFECTION
ANAEMIA
3
SS
HIV INFECTION
ARTHRALGIA
2
SS
HIV INFECTION
ARTHRITIS
2
SS
HIV INFECTION
ASTHENIA
7
SS
HIV INFECTION
BLOOD ALKALINE PHOSPHATASE INCREASED
7
SS
HIV INFECTION
BLOOD BILIRUBIN INCREASED
24
SS
HIV INFECTION
BLOOD CALCIUM DECREASED
7
SS
HIV INFECTION
BLOOD LACTATE DEHYDROGENASE INCREASED
24
SS
HIV INFECTION
BLOOD LACTIC ACID INCREASED
3
SS
HIV INFECTION
BLOOD THYROID STIMULATING HORMONE INCREASED
2
SS
HIV INFECTION
BOVINE TUBERCULOSIS
24
SS
HIV INFECTION
BRAIN OEDEMA
24
SS
HIV INFECTION
CD4 LYMPHOCYTES INCREASED
17
SS
HIV INFECTION
CEREBRAL TOXOPLASMOSIS
17
SS
HIV INFECTION
CHRONIC HEPATITIS
4
SS
HIV INFECTION
COAGULOPATHY
24
SS
HIV INFECTION
CONDITION AGGRAVATED
34
SS
HIV INFECTION
CONVULSION
24
SS
HIV INFECTION
CRYOGLOBULINS PRESENT
2
SS
HIV INFECTION
DIARRHOEA
20
SS
HIV INFECTION
DRUG INTOLERANCE
3
SS
HIV INFECTION
DRUG RESISTANCE
17
SS
HIV INFECTION
DRY EYE
4
SS
HIV INFECTION
DYSPHONIA
2
SS
HIV INFECTION
EAR INFECTION
17
SS
HIV INFECTION
ENOPHTHALMOS
6
SS
HIV INFECTION
EPILEPSY
17
SS
HIV INFECTION
FACIAL WASTING
2
SS
HIV INFECTION
FOETAL EXPOSURE DURING PREGNANCY
3
SS
HIV INFECTION
GAMMA-GLUTAMYLTRANSFERASE INCREASED
7
SS
HIV INFECTION
GASTROINTESTINAL DISORDER
17
SS
HIV INFECTION
GENERALISED OEDEMA
2
SS
HIV INFECTION
HAEMORRHAGE
24
SS
HIV INFECTION
HEPATIC CIRRHOSIS
24
SS
HIV INFECTION
HEPATIC ENCEPHALOPATHY
24
SS
HIV INFECTION
HEPATIC ENZYME INCREASED
4
SS
HIV INFECTION
HEPATIC FAILURE
24
SS
HIV INFECTION
HEPATITIS B
24
SS
HIV INFECTION
HEPATOTOXICITY
17
SS
HIV INFECTION
HERPES SIMPLEX
3
SS
HIV INFECTION
HYPERSENSITIVITY
3
SS
HIV INFECTION
HYPERTHYROIDISM
2
SS
HIV INFECTION
HYPOTHYROIDISM
2
SS
HIV INFECTION
IMMUNE RECONSTITUTION SYNDROME
61
SS
HIV INFECTION
INCORRECT DOSE ADMINISTERED
3
SS
HIV INFECTION
JAUNDICE
15
SS
HIV INFECTION
LAGOPHTHALMOS
6
SS
HIV INFECTION
LETHARGY
2
SS
HIV INFECTION
LIPOATROPHY
7
SS
HIV INFECTION
LIVER FUNCTION TEST ABNORMAL
24
SS
HIV INFECTION
LYMPHADENITIS
24
SS
HIV INFECTION
MATERNAL EXPOSURE DURING PREGNANCY
5
SS
HIV INFECTION
MEDICATION ERROR
1
SS
HIV INFECTION
MENINGITIS
17
SS
HIV INFECTION
MENTAL STATUS CHANGES
24
SS
HIV INFECTION
METABOLIC ACIDOSIS
1
SS
HIV INFECTION
MONOPLEGIA
17
SS
HIV INFECTION
MUSCLE ATROPHY
3
SS
HIV INFECTION
MYASTHENIA GRAVIS
15
SS
HIV INFECTION
NAUSEA
20
SS
HIV INFECTION
NEOPLASM MALIGNANT
2
SS
HIV INFECTION
NEUTROPENIA
1
SS
HIV INFECTION
NEUTROPENIA NEONATAL
3
SS
HIV INFECTION
OESOPHAGEAL CANDIDIASIS
17
SS
HIV INFECTION
OSTEOPOROSIS
28
SS
HIV INFECTION
PANCYTOPENIA
7
SS
HIV INFECTION
PNEUMONIA
1
SS
HIV INFECTION
PNEUMONIA STREPTOCOCCAL
17
SS
HIV INFECTION
POLYNEUROPATHY
17
SS
HIV INFECTION
PUNCTATE KERATITIS
2
SS
HIV INFECTION
QUADRIPARESIS
17
SS
HIV INFECTION
RASH
15
SS
HIV INFECTION
RHEUMATOID ARTHRITIS
2
SS
HIV INFECTION
RHEUMATOID FACTOR INCREASED
2
SS
HIV INFECTION
SCROTAL ULCER
3
SS
HIV INFECTION
SEPSIS
17
SS
HIV INFECTION
SINUS BRADYCARDIA
3
SS
HIV INFECTION
SKIN ULCER
7
SS
HIV INFECTION
SQUAMOUS CELL CARCINOMA
2
SS
HIV INFECTION
SYNOVITIS
2
SS
HIV INFECTION
TOXICITY TO VARIOUS AGENTS
25
SS
HIV INFECTION
TREATMENT FAILURE
17
SS
HIV INFECTION
TREATMENT NONCOMPLIANCE
17
SS
HIV INFECTION
URINARY TRACT INFECTION
7
SS
HIV INFECTION
VACCINATION FAILURE
24
SS
HIV INFECTION
VIITH NERVE PARALYSIS
17
SS
HIV INFECTION
VIRAL LOAD INCREASED
17
SS
HIV INFECTION
VOMITING
20
SS
HIV INFECTION
WEIGHT INCREASED
5
SS
HIV INFECTION
WOUND
2
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
AORTIC STENOSIS
9
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
CLEFT LIP AND PALATE
9
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
CONGENITAL AORTIC ANOMALY
9
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
CYTOGENETIC ABNORMALITY
9
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
FOETAL EXPOSURE DURING PREGNANCY
9
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
HEART DISEASE CONGENITAL
9
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
PERSISTENT LEFT SUPERIOR VENA CAVA
9
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
POLYHYDRAMNIOS
9
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
SINGLE UMBILICAL ARTERY
9
SS
MATERNAL EXPOSURE TIMING UNSPECIFIED
VENTRICULAR SEPTAL DEFECT
9
SS
MYASTHENIA GRAVIS
CONDITION AGGRAVATED
2
SS
MYASTHENIA GRAVIS
IMMUNE RECONSTITUTION SYNDROME
2
SS
MYASTHENIA GRAVIS
JAUNDICE
2
SS
MYASTHENIA GRAVIS
MYASTHENIA GRAVIS
2
SS
MYASTHENIA GRAVIS
RASH
2
SS
PNEUMONIA STREPTOCOCCAL
CD4 LYMPHOCYTES INCREASED
1
SS
PNEUMONIA STREPTOCOCCAL
CEREBRAL TOXOPLASMOSIS
1
SS
PNEUMONIA STREPTOCOCCAL
DIARRHOEA
1
SS
PNEUMONIA STREPTOCOCCAL
DRUG RESISTANCE
1
SS
PNEUMONIA STREPTOCOCCAL
EAR INFECTION
1
SS
PNEUMONIA STREPTOCOCCAL
EPILEPSY
1
SS
PNEUMONIA STREPTOCOCCAL
GASTROINTESTINAL DISORDER
1
SS
PNEUMONIA STREPTOCOCCAL
HEPATOTOXICITY
1
SS
PNEUMONIA STREPTOCOCCAL
IMMUNE RECONSTITUTION SYNDROME
1
SS
PNEUMONIA STREPTOCOCCAL
MENINGITIS
1
SS
PNEUMONIA STREPTOCOCCAL
MONOPLEGIA
1
SS
PNEUMONIA STREPTOCOCCAL
NAUSEA
1
SS
PNEUMONIA STREPTOCOCCAL
OESOPHAGEAL CANDIDIASIS
1
SS
PNEUMONIA STREPTOCOCCAL
PNEUMONIA STREPTOCOCCAL
1
SS
PNEUMONIA STREPTOCOCCAL
POLYNEUROPATHY
1
SS
PNEUMONIA STREPTOCOCCAL
QUADRIPARESIS
1
SS
PNEUMONIA STREPTOCOCCAL
SEPSIS
1
SS
PNEUMONIA STREPTOCOCCAL
TREATMENT FAILURE
1
SS
PNEUMONIA STREPTOCOCCAL
TREATMENT NONCOMPLIANCE
1
SS
PNEUMONIA STREPTOCOCCAL
VIITH NERVE PARALYSIS
1
SS
PNEUMONIA STREPTOCOCCAL
VIRAL LOAD INCREASED
1
SS
PNEUMONIA STREPTOCOCCAL
VOMITING
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
ACUTE HEPATIC FAILURE
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
ALANINE AMINOTRANSFERASE INCREASED
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
AMNESIA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD BILIRUBIN INCREASED
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD LACTATE DEHYDROGENASE INCREASED
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
BOVINE TUBERCULOSIS
24
SS
PRODUCT USED FOR UNKNOWN INDICATION
BRAIN OEDEMA
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
COAGULOPATHY
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
CONDITION AGGRAVATED
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
CONVULSION
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
COUGH
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
DYSPNOEA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
FOETAL EXPOSURE DURING PREGNANCY
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
GESTATIONAL DIABETES
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
HAEMORRHAGE
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATIC CIRRHOSIS
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATIC ENCEPHALOPATHY
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATIC FAILURE
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATITIS B
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATOMEGALY
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
HEPATOTOXICITY
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
HYPERSENSITIVITY
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
IMMUNE RECONSTITUTION SYNDROME
24
SS
PRODUCT USED FOR UNKNOWN INDICATION
LACTIC ACIDOSIS
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
LIVE BIRTH
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
LIVER FUNCTION TEST ABNORMAL
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
LYMPHADENITIS
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
MATERNAL EXPOSURE DURING PREGNANCY
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
MENTAL STATUS CHANGES
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
PYREXIA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
RENAL FAILURE ACUTE
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
TOXICITY TO VARIOUS AGENTS
12
SS
PRODUCT USED FOR UNKNOWN INDICATION
VACCINATION FAILURE
12
SS
PROPHYLAXIS
DEVELOPMENTAL DELAY
3
SS
PROPHYLAXIS
FOETAL EXPOSURE DURING PREGNANCY
3
SS
PROPHYLAXIS
HEPATOSPLENOMEGALY
3
SS
PROPHYLAXIS
LACTIC ACIDOSIS
3
SS
PROPHYLAXIS
LYMPHADENITIS
3
SS
PROPHYLAXIS
LYMPHADENOPATHY
3
SS
PROPHYLAXIS
MUSCLE SPASTICITY
3
SS
PROPHYLAXIS AGAINST HIV INFECTION
ACCIDENTAL OVERDOSE
1
SS
PROPHYLAXIS AGAINST HIV INFECTION
DIABETES MELLITUS
3
SS
PROPHYLAXIS AGAINST HIV INFECTION
MEDICATION ERROR
1
SS
PROPHYLAXIS AGAINST HIV INFECTION
TOXICITY TO VARIOUS AGENTS
1
SS
TUBERCULOSIS
ACUTE HEPATIC FAILURE
42
SS
TUBERCULOSIS
ALANINE AMINOTRANSFERASE INCREASED
42
SS
TUBERCULOSIS
ANAEMIA
4
SS
TUBERCULOSIS
ARRHYTHMIA
4
SS
TUBERCULOSIS
ASCITES
4
SS
TUBERCULOSIS
ASPARTATE AMINOTRANSFERASE INCREASED
4
SS
TUBERCULOSIS
BLOOD BILIRUBIN INCREASED
42
SS
TUBERCULOSIS
BLOOD LACTATE DEHYDROGENASE INCREASED
42
SS
TUBERCULOSIS
BOVINE TUBERCULOSIS
42
SS
TUBERCULOSIS
BRAIN OEDEMA
42
SS
TUBERCULOSIS
CARDIAC FAILURE CONGESTIVE
4
SS
TUBERCULOSIS
COAGULOPATHY
42
SS
TUBERCULOSIS
CONDITION AGGRAVATED
42
SS
TUBERCULOSIS
CONVULSION
42
SS
TUBERCULOSIS
DIARRHOEA
4
SS
TUBERCULOSIS
HAEMORRHAGE
42
SS
TUBERCULOSIS
HEPATIC CIRRHOSIS
42
SS
TUBERCULOSIS
HEPATIC ENCEPHALOPATHY
42
SS
TUBERCULOSIS
HEPATIC FAILURE
42
SS
TUBERCULOSIS
HEPATITIS B
42
SS
TUBERCULOSIS
HYPERTENSION
4
SS
TUBERCULOSIS
HYPOTENSION
4
SS
TUBERCULOSIS
IMMUNE RECONSTITUTION SYNDROME
42
SS
TUBERCULOSIS
LIVER FUNCTION TEST ABNORMAL
42
SS
TUBERCULOSIS
LOBAR PNEUMONIA
4
SS
TUBERCULOSIS
LYMPHADENITIS
42
SS
TUBERCULOSIS
MENTAL DISORDER
4
SS
TUBERCULOSIS
MENTAL STATUS CHANGES
42
SS
TUBERCULOSIS
MOTOR NEURONE DISEASE
4
SS
TUBERCULOSIS
NEUTROPENIA
4
SS
TUBERCULOSIS
PEPTIC ULCER
4
SS
TUBERCULOSIS
RASH
4
SS
TUBERCULOSIS
THROMBOCYTOPENIA
4
SS
TUBERCULOSIS
TOXICITY TO VARIOUS AGENTS
42
SS
TUBERCULOSIS
VACCINATION FAILURE
42
SS
URTICARIA
ACIDOSIS
1
SS
URTICARIA
ALANINE AMINOTRANSFERASE INCREASED
1
SS
URTICARIA
BLOOD LACTIC ACID INCREASED
1
SS
URTICARIA
FOETAL EXPOSURE DURING PREGNANCY
1
SS
URTICARIA
INCORRECT DOSE ADMINISTERED
1
SS
URTICARIA
NEUTROPENIA NEONATAL
1
SS
URTICARIA
SINUS BRADYCARDIA
1
C
ANTIRETROVIRAL THERAPY
FOETAL GROWTH RESTRICTION
4
C
ANTIRETROVIRAL THERAPY
MATERNAL EXPOSURE DURING PREGNANCY
4
C
ANTIRETROVIRAL THERAPY
PREMATURE BABY
4
C
ASTHMA
ASTHMA
1
C
ASTHMA
CUSHING'S SYNDROME
2
C
ASTHMA
IATROGENIC INJURY
1
C
ASTHMA
INSULIN RESISTANCE
1
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
ABDOMINAL DISTENSION
2
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
FLUID RETENTION
2
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
PNEUMONIA
2
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
SWELLING FACE
2
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
WEIGHT INCREASED
2
C
CONSTIPATION
ABDOMINAL PAIN
1
C
CONSTIPATION
DIARRHOEA
1
C
CONSTIPATION
HAEMOGLOBIN DECREASED
1
C
CONSTIPATION
HEPATOSPLENOMEGALY
1
C
CONSTIPATION
PAIN
1
C
CONSTIPATION
SICKLE CELL ANAEMIA WITH CRISIS
1
C
CONSTIPATION
SPLENOMEGALY
1
C
CONSTIPATION
VOMITING
1
C
DEPRESSION
ABDOMINAL PAIN
1
C
DEPRESSION
DIARRHOEA
1
C
DEPRESSION
HAEMOGLOBIN DECREASED
1
C
DEPRESSION
HEPATOSPLENOMEGALY
1
C
DEPRESSION
PAIN
1
C
DEPRESSION
SICKLE CELL ANAEMIA WITH CRISIS
1
C
DEPRESSION
SPLENOMEGALY
1
C
DEPRESSION
VOMITING
1
C
HIV INFECTION
ABDOMINAL DISTENSION
4
C
HIV INFECTION
ABDOMINAL MASS
5
C
HIV INFECTION
ABDOMINAL PAIN
3
C
HIV INFECTION
ANAEMIA
3
C
HIV INFECTION
ASCITES
1
C
HIV INFECTION
ASTHMA
1
C
HIV INFECTION
CACHEXIA
4
C
HIV INFECTION
CAESAREAN SECTION
3
C
HIV INFECTION
CANDIDURIA
1
C
HIV INFECTION
CONDITION AGGRAVATED
3
C
HIV INFECTION
COUGH
2
C
HIV INFECTION
CUSHING'S SYNDROME
2
C
HIV INFECTION
DEATH
2
C
HIV INFECTION
DIARRHOEA
3
C
HIV INFECTION
FLUID RETENTION
4
C
HIV INFECTION
FOETAL CARDIAC DISORDER
2
C
HIV INFECTION
GENERAL PHYSICAL HEALTH DETERIORATION
1
C
HIV INFECTION
HAEMOGLOBIN DECREASED
3
C
HIV INFECTION
HEPATIC CIRRHOSIS
1
C
HIV INFECTION
HEPATOSPLENOMEGALY
3
C
HIV INFECTION
HISTOPLASMOSIS
1
C
HIV INFECTION
IATROGENIC INJURY
1
C
HIV INFECTION
IMMUNE RECONSTITUTION SYNDROME
1
C
HIV INFECTION
INSULIN RESISTANCE
1
C
HIV INFECTION
INTERSTITIAL GRANULOMATOUS DERMATITIS
1
C
HIV INFECTION
LARYNGEAL DISORDER
2
C
HIV INFECTION
MATERNAL EXPOSURE TIMING UNSPECIFIED
3
C
HIV INFECTION
NAUSEA
1
C
HIV INFECTION
NEPHROPATHY
2
C
HIV INFECTION
OESOPHAGEAL ATRESIA
2
C
HIV INFECTION
OPERATIVE HAEMORRHAGE
3
C
HIV INFECTION
OXYGEN SATURATION DECREASED
2
C
HIV INFECTION
PAIN
3
C
HIV INFECTION
PNEUMONIA
4
C
HIV INFECTION
PYREXIA
4
C
HIV INFECTION
RENAL DISORDER
3
C
HIV INFECTION
RETCHING
1
C
HIV INFECTION
SALIVARY HYPERSECRETION
2
C
HIV INFECTION
SICKLE CELL ANAEMIA WITH CRISIS
3
C
HIV INFECTION
SPLENOMEGALY
3
C
HIV INFECTION
SWELLING FACE
4
C
HIV INFECTION
SYPHILIS
4
C
HIV INFECTION
THERAPY CESSATION
1
C
HIV INFECTION
TRACHEOMALACIA
2
C
HIV INFECTION
UTERINE HAEMORRHAGE
3
C
HIV INFECTION
VOMITING
4
C
HIV INFECTION
WEIGHT INCREASED
4
C
MATERNAL EXPOSURE DURING PREGNANCY
PREMATURE BABY
1
C
MATERNAL EXPOSURE DURING PREGNANCY
TRANSIENT TACHYPNOEA OF THE NEWBORN
1
C
PAIN
ABDOMINAL DISTENSION
2
C
PAIN
FLUID RETENTION
2
C
PAIN
PNEUMONIA
2
C
PAIN
SWELLING FACE
2
C
PAIN
WEIGHT INCREASED
2
C
PRODUCT USED FOR UNKNOWN INDICATION
ARTERIAL DISORDER
2
C
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD PRESSURE ABNORMAL
2
C
PRODUCT USED FOR UNKNOWN INDICATION
CAESAREAN SECTION
11
C
PRODUCT USED FOR UNKNOWN INDICATION
OEDEMA
2
C
PROPHYLAXIS
CACHEXIA
1
C
PROPHYLAXIS
FOETAL GROWTH RESTRICTION
1
C
PROPHYLAXIS
MATERNAL EXPOSURE DURING PREGNANCY
1
C
PROPHYLAXIS
PREMATURE BABY
1
C
PROPHYLAXIS
PYREXIA
1
C
PROPHYLAXIS
RENAL DISORDER
1
C
PROPHYLAXIS
SYPHILIS
1
C
PROPHYLAXIS AGAINST HIV INFECTION
PREMATURE BABY
1
C
PROPHYLAXIS AGAINST HIV INFECTION
TRANSIENT TACHYPNOEA OF THE NEWBORN
1
C
SICKLE CELL ANAEMIA
ABDOMINAL PAIN
1
C
SICKLE CELL ANAEMIA
DIARRHOEA
1
C
SICKLE CELL ANAEMIA
HAEMOGLOBIN DECREASED
1
C
SICKLE CELL ANAEMIA
HEPATOSPLENOMEGALY
1
C
SICKLE CELL ANAEMIA
PAIN
1
C
SICKLE CELL ANAEMIA
SICKLE CELL ANAEMIA WITH CRISIS
1
C
SICKLE CELL ANAEMIA
SPLENOMEGALY
1
C
SICKLE CELL ANAEMIA
VOMITING
1
C
VITAMIN SUPPLEMENTATION
CACHEXIA
1
C
VITAMIN SUPPLEMENTATION
PYREXIA
1
C
VITAMIN SUPPLEMENTATION
RENAL DISORDER
1
C
VITAMIN SUPPLEMENTATION
SYPHILIS
1
Ads by Google